Esperion Therapeutics
ESPR
#6506
Rank
ยฃ0.62 B
Marketcap
ยฃ2.43
Share price
0.00%
Change (1 day)
30.85%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2026 (TTM): -ยฃ0.01603

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.01528. In 2025 the company made an earnings per share (EPS) of -ยฃ0.09934 an increase over its 2024 EPS that were of -ยฃ0.18.

EPS history for Esperion Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.01603-83.86%
2025-ยฃ0.09934-43.48%
2024-ยฃ0.18-89.15%
2023-ยฃ1.62-40.28%
2022-ยฃ2.71-62.87%
2021-ยฃ7.3180.38%
2020-ยฃ4.0550.14%
2019-ยฃ2.70-53.18%
2018-ยฃ5.767.41%
2017-ยฃ5.36110.81%
2016-ยฃ2.5447.35%
2015-ยฃ1.730.89%
2014-ยฃ1.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.54-3,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ35.90-235,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ3.97 25,850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ0.11 600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-ยฃ0.08406 450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-ยฃ0.06877 350.00%๐Ÿ‡บ๐Ÿ‡ธ USA